PPAR-gamma ACTIVATORS, HDAC INHIBITORS AND THEIR THERAPEUTICAL USAGES

• 收藏
• 分享

专利权人:

THERIAC BIOMEDICALE INC.

发明人:

Tony ANTAKLY

申请号：

US16226436

公开号：

US20190298673A1

申请日:

2018.12.19

申请国别(地区):

US

年份:

2019

代理人:

摘要：

The invention relates to a pharmaceutical composition for induction of activity of a nuclear receptor PPARγ and inhibition of HDAC in a subject in need thereof, which comprises a synergistic combination of benzoate and phenylbutyrate and/or phenylacetate in association with a pharmaceutical carrier.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/